City
Epaper

South Korea's pharmaceutical, biotechnology exports surge 55 pc in H1

By IANS | Updated: June 29, 2024 11:50 IST

Seoul, June 29 South Korea's exports of pharmaceutical and biotechnologies surged from a year earlier in the first ...

Open in App

Seoul, June 29 South Korea's exports of pharmaceutical and biotechnologies surged from a year earlier in the first half of the year, data showed on Saturday.

In the first six months of the year, the country exported 4.5 trillion won ($3.26 billion) worth of pharmaceutical and biotechnologies, up 55 per cent from 2.9 trillion won (about $2.09 billion) for the same period last year, according to the data from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.

The number of export deals dropped to seven from 12 over the cited period, but the amount of each deal grew sharply, the association noted, adding that each of the three deals signed this month was worth over 500 billion won, reports Yonhap News Agency.

At the current rate, the country's annual total is expected to reach 8 trillion won, according to the association.

"This means the competitiveness of our country's pharmaceutical and biopharmaceutical technologies have significantly improved," an association official said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

TechnologySouth Korean startup again delays 1st commercial orbit launch

EntertainmentVivaan Shah sheds lights on his 'Ikkis' role

BusinessSouth Korean startup again delays 1st commercial orbit launch

NationalUttarakhand CM Pushkar Singh Dhami hails PM Modi for passage of G RAM G Bill in Parliament

TechnologySEBI to examine challenges preventing electronic gold receipt acceptance: Chairman

Business Realted Stories

BusinessSEBI to examine challenges preventing electronic gold receipt acceptance: Chairman

Business38 Railways projects worth Rs 89,780 crore sanctioned in Maharashtra: Centre

BusinessGlobal M&A activity surges as AI and mega deals drive strategic growth in 2026: Goldman Sachs

BusinessRBI likely to pause rate cuts amid new CPI series unless growth falters: Report

BusinessBSE proposes cap on free order messages, plans charges beyond 10-crore daily limit